Literature DB >> 23271702

Correlates of relative resistance against low-dose rectal simian immunodeficiency virus challenges in peripheral blood mononuclear cells of vaccinated rhesus macaques.

Raj Kurupati1, Steve Tuyishime, Andrew V Kossenkov, Marina Sazanovich, Larissa H Haut, Marcio O Lasaro, Sarah J Ratcliffe, Steven E Bosinger, Diane G Carnathan, Mark Lewis, Louise C Showe, Guido Silvestri, Hildegund C J Ertl.   

Abstract

In this study, we compared the immunogenicity and protection from repeated low-dose intrarectal SIVmac251 challenge in two groups of vaccinated RMs. Animals were immunized with live SIVmac239, which had been attenuated by a deletion of the nef sequence, or they were vaccinated twice with an E1-deleted AdHu5, expressing SIVmac239gag. The vaccinated animals and a cohort of unvaccinated control animals were then challenged 10 times in weekly intervals with low doses of SIVmac251 given rectally. Our results confirm previous studies showing that whereas SIVΔnef provides some degree of protection against viral acquisition after repeated low-dose rectal SIVmac251 challenges, vaccination with an AdHu5gag vaccine designed to induce only antiviral T cell responses is ineffective. As immunological analyses of prechallenge, vaccine-induced T and B cell responses failed to reveal correlates of protection that distinguished the more susceptible from the more resistant vaccinated animals, we carried out RNA-Seq studies of paired pre- and postvaccination samples to identify transcriptional patterns that correlated with the differences in response. We show that gene expression signatures associated with the delayed SIV infection seen in some AdHu5gag recipients were largely present in prevaccination samples of those animals. In contrast, the responding SIVΔnef-immunized animals showed a predominance of vaccine-induced changes, thus enabling us to define inherited and vaccine-induced gene expression signatures and their associated pathways that may play a role in preventing SIV acquisition.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23271702      PMCID: PMC3579023          DOI: 10.1189/jlb.0612287

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  33 in total

1.  A novel antioxidant N-acetylcysteine amide prevents gp120- and Tat-induced oxidative stress in brain endothelial cells.

Authors:  Tulin Otamis Price; Fikriye Uras; William A Banks; Nuran Ercal
Journal:  Exp Neurol       Date:  2006-06-05       Impact factor: 5.330

2.  Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with dna and recombinant adenoviral vaccine vectors expressing Gag.

Authors:  Danilo R Casimiro; Fubao Wang; William A Schleif; Xiaoping Liang; Zhi-Qiang Zhang; Timothy W Tobery; Mary-Ellen Davies; Adrian B McDermott; David H O'Connor; Arthur Fridman; Ansu Bagchi; Lynda G Tussey; Andrew J Bett; Adam C Finnefrock; Tong-ming Fu; Aimin Tang; Keith A Wilson; Minchun Chen; Helen C Perry; Gwendolyn J Heidecker; Daniel C Freed; Anthony Carella; Kara S Punt; Kara J Sykes; Lingyi Huang; Virginia I Ausensi; Margaret Bachinsky; Usha Sadasivan-Nair; David I Watkins; Emilio A Emini; John W Shiver
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

3.  Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.

Authors:  John W Shiver; Tong-Ming Fu; Ling Chen; Danilo R Casimiro; Mary-Ellen Davies; Robert K Evans; Zhi-Qiang Zhang; Adam J Simon; Wendy L Trigona; Sheri A Dubey; Lingyi Huang; Virginia A Harris; Romnie S Long; Xiaoping Liang; Larry Handt; William A Schleif; Lan Zhu; Daniel C Freed; Natasha V Persaud; Liming Guan; Kara S Punt; Aimin Tang; Minchun Chen; Keith A Wilson; Kelly B Collins; Gwendolyn J Heidecker; V Rose Fernandez; Helen C Perry; Joseph G Joyce; Karen M Grimm; James C Cook; Paul M Keller; Denise S Kresock; Henryk Mach; Robert D Troutman; Lynne A Isopi; Donna M Williams; Zheng Xu; Kathryn E Bohannon; David B Volkin; David C Montefiori; Ayako Miura; Georgia R Krivulka; Michelle A Lifton; Marcelo J Kuroda; Jörn E Schmitz; Norman L Letvin; Michael J Caulfield; Andrew J Bett; Rima Youil; David C Kaslow; Emilio A Emini
Journal:  Nature       Date:  2002-01-17       Impact factor: 49.962

4.  Nuclear export of simian immunodeficiency virus Vpx protein.

Authors:  Prabhat K Singhal; P Rajendra Kumar; Malireddi R K Subba Rao; Sundarasamy Mahalingam
Journal:  J Virol       Date:  2006-09-20       Impact factor: 5.103

5.  SerpinB2 is an inducible host factor involved in enhancing HIV-1 transcription and replication.

Authors:  Grant A Darnell; Wayne A Schroder; Joy Gardner; David Harrich; Hong Yu; Robert L Medcalf; David Warrilow; Toni M Antalis; Secondo Sonza; Andreas Suhrbier
Journal:  J Biol Chem       Date:  2006-08-21       Impact factor: 5.157

Review 6.  Protective immunity induced by live attenuated simian immunodeficiency virus.

Authors:  R P Johnson; R C Desrosiers
Journal:  Curr Opin Immunol       Date:  1998-08       Impact factor: 7.486

7.  Processing of an HIV replication intermediate by the human DNA replication enzyme FEN1.

Authors:  J A Rumbaugh; G M Fuentes; R A Bambara
Journal:  J Biol Chem       Date:  1998-10-30       Impact factor: 5.157

8.  Identification of Staufen in the human immunodeficiency virus type 1 Gag ribonucleoprotein complex and a role in generating infectious viral particles.

Authors:  Laurent Chatel-Chaix; Jean-Francois Clément; Catherine Martel; Véronique Bériault; Anne Gatignol; Luc DesGroseillers; Andrew J Mouland
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

9.  Identification of a novel human zinc finger protein that specifically interacts with the activation domain of lentiviral Tat proteins.

Authors:  R A Fridell; L S Harding; H P Bogerd; B R Cullen
Journal:  Virology       Date:  1995-06-01       Impact factor: 3.616

10.  Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys.

Authors:  Dan H Barouch; Jinyan Liu; Hualin Li; Lori F Maxfield; Peter Abbink; Diana M Lynch; M Justin Iampietro; Adam SanMiguel; Michael S Seaman; Guido Ferrari; Donald N Forthal; Ilnour Ourmanov; Vanessa M Hirsch; Angela Carville; Keith G Mansfield; Donald Stablein; Maria G Pau; Hanneke Schuitemaker; Jerald C Sadoff; Erik A Billings; Mangala Rao; Merlin L Robb; Jerome H Kim; Mary A Marovich; Jaap Goudsmit; Nelson L Michael
Journal:  Nature       Date:  2012-01-04       Impact factor: 49.962

View more
  4 in total

1.  Enhancement of recombinant adenovirus vaccine-induced primary but not secondary systemic and mucosal immune responses by all-trans retinoic acid.

Authors:  Steven Tuyishime; Larissa H Haut; Caihong Zhu; Hildegund C J Ertl
Journal:  Vaccine       Date:  2014-04-26       Impact factor: 3.641

2.  Antibody responses to prime-boost vaccination with an HIV-1 gp145 envelope protein and chimpanzee adenovirus vectors expressing HIV-1 gp140.

Authors:  Kristel L Emmer; Lindsay Wieczorek; Steven Tuyishime; Sebastian Molnar; Victoria R Polonis; Hildegund C J Ertl
Journal:  AIDS       Date:  2016-10-23       Impact factor: 4.177

Review 3.  Using nonhuman primates to model HIV transmission.

Authors:  Christine M Fennessey; Brandon F Keele
Journal:  Curr Opin HIV AIDS       Date:  2013-07       Impact factor: 4.283

4.  Signatures in Simian Immunodeficiency Virus SIVsmE660 Envelope gp120 Are Associated with Mucosal Transmission but Not Vaccination Breakthrough in Rhesus Macaques.

Authors:  S Abigail Smith; Katie M Kilgore; Sudhir Pai Kasturi; Bali Pulendran; Eric Hunter; Rama R Amara; Cynthia A Derdeyn
Journal:  J Virol       Date:  2015-12-16       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.